SCM
AGN

Sandler Capital Management’s Allergan plc AGN Stock Holding History

Sandler Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,500
Closed -$922K – 151
2017
Q3 		$922K Hold
4,500
– – 0.11% 89
2017
Q2 		$1.09M Buy
4,500
+745
+20% +$175K 0.12% 109
2017
Q1 		$897K Buy
3,755
+100
+3% +$23.3K 0.06% 151
2016
Q4 		$768K Buy
+3,655
New +$757K 0.07% 123

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Sandler Capital Management's AGN Position: Q4 2017 in Review

Sandler Capital Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 4,500 shares — an estimated $922K sold.

Sandler Capital Management first reported a position in AGN in Q4 2016 and held it in 4 quarters. The position peaked at $1.09M in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Sandler Capital Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Sandler Capital Management sold 4,500 Allergan plc shares in Q4 2017, an estimated $922K.
  • Sandler Capital Management first reported a position in Allergan plc in Q4 2016 and held it in 4 quarters.
  • Sandler Capital Management's Allergan plc position peaked at $1.09M in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Sandler Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.